Lv1
56 积分 2024-05-07 加入
Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trial
11个月前
已完结
CT269: First-in-human trial in patients with metastatic colorectal cancer using CRISPR-engineered tumor infiltrating lymphocytes in which the intracellular immune checkpoint CISH is inhibited
11个月前
已关闭
IL-27 elicits a cytotoxic CD8+ T cell program to enforce tumour control
1年前
已完结
皖公网安备34019202002308
